Study to Assess Sarilumab in Halting Progression of Morphea

Clinical trial NCT03679845 · WITHDRAWN

Trial details

NCT number: NCT03679845
Sponsor: Massachusetts General Hospital
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Morphea, Plaque Form

Start date: 2019-09-01
Primary completion: 2021-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.